LOS ANGELES, May 08, 2025 (GLOBE NEWSWIRE) — PeakMetrics, a leader in AI-driven narrative intelligence, is pleased to announce the appointment of Noha Georges to its Board of Advisors. Georges brings over two decades of global experience in strategic communications, reputation management, and public affairs, with deep expertise in both
ZURICH, May 08, 2025 (GLOBE NEWSWIRE) — The European Academy of Allergy & Clinical Immunology (EAACI), in partnership with the Hong Kong Institute of Allergy (HKIA), is proud to announce the inaugural EAACI Hong Kong Allergy School. This significant milestone will unfold in Hong Kong – Asia’s World City –
Nyxoah to Release First Quarter 2025 Financial Results on May 14, 2025 Mont-Saint-Guibert, Belgium – Wednesday May 7, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced that the
Unified Engagement from Zoom CX and ServiceNow integrates voice, video, and digital channels directly within the ServiceNow AI Platform for a simpler agent experience and more personalized customer engagements LAS VEGAS, May 07, 2025 (GLOBE NEWSWIRE) — Zoom Communications Inc. (NASDAQ: ZM) and ServiceNow (NYSE: NOW), the AI platform for
This year’s national winners from Royal International School, Kurunegala in Sri Lanka focused on a new initiative at their school, enabling students to benefit from outdoor learning. The first and second runner-up winners, selected from the national entries, were Brisbane International School and Musaeus College. On a global scale, 642
The winner of the 2025 ‘Your World’ competition by British Council Partner Schools is Scoris International School from Uganda. Their project addressing unemployment among women in their country was selected from 642 entries submitted by 3,210 students across 34 countries. Participants gain crucial skills in problem-solving, communication, and creativity, preparing
Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr.
SINGAPORE, May 06, 2025 (GLOBE NEWSWIRE) — Antalpha Platform Holding Company (“Antalpha” or the “Company”) today announced that it has launched the roadshow for its proposed initial public offering of 3,850,000 ordinary shares with expected pricing between $11.00 and $13.00 per ordinary share. Antalpha expects to grant the underwriters a